Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Maravai LifeSciences Holdings Community
NasdaqGS:MRVI Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Maravai LifeSciences Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Maravai LifeSciences Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Flanders Facilities And New Acquisitions Will Create Future Opportunity
Key Takeaways Strategic partnerships and new product launches drive diversification and growth across the business. Acquisitions and operational facilities boost margins and support earnings through technology enhancements and increased demand.
View narrative
US$5.10
FV
58.4% undervalued
intrinsic discount
-4.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
MRVI
MRVI
Maravai LifeSciences Holdings
Your Fair Value
US$
Current Price
US$2.12
54.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-145m
883m
2015
2018
2021
2024
2025
2027
2030
Revenue US$194.6m
Earnings US$23.4m
Advanced
Set Fair Value